Anemia Mukt Bharat
Anemia a Pandemic in India
According to WHO’s dashboard, it is seen that the prevalence of anemia in women of reproductive age in India was 53% in 2019, the fifth-highest globally, after Yemen, Mali, Benin, and Nigeria.
There are many causes of anemia, out of which Iron Deficiency accounts for about 50 percent of anemia in school going children and among women of reproductive age-group, and 80 percent in children of 2–5 years of age.
(Source: Vikaspedia , an online information guide launched by the Government of India’s Ministry of Communications and Information Technology.)
Classification of Anemia as per National Family Health Survey (NFHS)
| Classification | Normal | Moderate | Severe |
| Men | 13g/dL& more | 9 – 11.9 g/dL | < 9 g/dL |
| Women(not pregnant) | 12g/dL& more | 7 – 9.9 g/dL | < 7 g/dL |
| Pregnant Women | 11g/dL& more | 7 – 9.9 g/dL | < 7 g/dL |
| Children | 11g/dL& more | 7 – 9.9 g/dL | < 7 g/dL |
(Source: National Family Health Survey 4 , 2015/16)
Anemia Mukt Bharat
India has been running the National Nutritional Anaemia Prophylaxis Programme (NNAPP) since 1970 to battle anemia , but unfortunately , in the last 10 years the percentage point reduction of anemia prevalence has been extremely low in most age groups.
Objectives
Considering the seriousness and gravity of the anemia situation in the country ,in 2018 , an integrated health programme named Anemia Mukt Bharat has been launched under The Ministry of Health & Family Welfare jointly with UNICEF.
The Anemia Mukt Bharat strategy has been designed to reduce prevalence of anemia by 3 percentage points per year among children, adolescents and women in the reproductive age group (15–49 years), between 2018 and 2022.
Beneficiaries & Target
The Anemia Mukt Bharat strategy is designed to be implemented in all villages, blocks, and districts of all the States/UTs of India through existing delivery platforms .The programme is estimated to reach out to 450 million beneficiaries
Anemia Mukt Bharat beneficiaries and anemia reduction targets for different age groups for 2022
| Age Group | Estd beneficiaries
(in millions) |
| Children (6–59 months) | 124 |
| Children (5–9 years) | 134 |
| Adolescent boys (10–19 years) | 47 |
| Adolescent girls (10–19 years) | 68 |
| Women of reproductive age (20–24 years) | 17 |
| Pregnant women | 30 |
| Lactating women | 27 |
| Total beneficiaries | ~450 million |
Beneficiary estimations are as per Census 2011 estimations for 2017.
Source https://vikaspedia.in/health/health-campaigns/anemia-mukt-bharat
Present Scenario
The COVID-19 pandemic has caused and is still causing a major hurdle for India for not being able to progress towards achieving country’ s target towards reduction of anemia.
The fifth and latest round of the National Family Health Survey, NFHS-5 has flagged a worrying trend: that instead of reduction in the percentage level, the percentage of anaemic individual actually rose in India in the last five years.
| Age Group | 2015-16 (NFHS-4) | 2019-21(NFHS-5) | *2022(Target) | ||
| Children 6 to 59 months | 58% | 67% | 40% | ||
| Adolescent Girls-15 to 19 Years | 54% | 59% | 36% | ||
| Women of Reproductive Age | 53% | 57% | 35% | ||
| Pregnant Women | 50% | 52% | 32% | ||
| Adolescent boys-15 to 19 Years | 29% | 31% | 11% | ||
| **Source https://anemiamuktbharat.info/home/target/ | |||||
AYURVEDA CAN HELP
While it is a humongous task to make India anemia free, Ayurveda brings a rays of hope to reduce Iron Deficiency Anemia in a very effective manner.
Kulerron- Anemia Reducing Ayurvedic Tonic by century old Branolia Chemicals, West Bengal
This Ayurvedic medicinal tonic was researched and developed by Branolia Chemical Works, a Herbal Pharmaceutical House, by exploiting a medicinal herb Kulekhara as a scientifically proven haemoglobin enhancer to reduce and fight Iron Deficiency Anemia.
Kulekhara is the primary ingredient of Kulerron, with few more health reviving Ayurvedic Herbs like Ashwagandha and Nagkesar it helps to increase haemoglobin and reduce anemia significantly. A rodent research showed that red blood cell level and WBC count were increased considerably with Kulerron’s regular application.
Kulerron is considered to be one of the best cost effective anemia reducing ayurvedic antidote and is being consumed by people across the country suffering from the disease to enhance haemoglobin and reduce anemia .This ayurvedic anemic medine has no adverse side effects.
We at Branolia , remain committed to the national fight against anemia and have extended the availability of Kulerron across the country through online at a very reasonable price.
[supsystic-social-sharing id="1"]
